Genmab

CEO - Jan van de Winkel
Denmark | Funding: $204.3M (+)
Website: http://www.genmab.com/
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Website: http://www.genmab.com/
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.

